Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT07225946

Public ClinicalTrials.gov record NCT07225946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label Study of Pasritamig (JNJ-78278343), a T-cell-engaging Agent Targeting Human Kallikrein 2, With Docetaxel Versus Docetaxel for Metastatic Castration-resistant Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxel in participants with metastatic castrate-resistant prostate cancer (mCRPC; a cancer of prostate, a male reproductive gland found below the bladder, that grows despite low levels of male hormones).

Study identification

NCT ID
NCT07225946
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
800 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2025
Primary completion
Nov 18, 2027
Completion
Jul 19, 2029
Last update posted
Aug 27, 2026

2025 – 2029

United States locations

U.S. sites
53
U.S. states
27
U.S. cities
49
Facility City State ZIP Site status
Arizona Clinical Trials Chandler Arizona 85225 Recruiting
Arkansas Urology Little Rock Arkansas 72211 Recruiting
MemorialCare Orange Coast Medical Center Fountain Valley California 92708 Recruiting
University Of California San Diego La Jolla California 92037 Recruiting
Cancer and Blood Specialty Clinic Los Alamitos California 90720 Recruiting
USC Norris Comprehensive Cancer Center Los Angeles California 90033 Recruiting
Valkyrie Clinical Trials Los Angeles California 90067 Recruiting
Kaiser Permanente Southern California Riverside California 92505 Recruiting
Sharp Center for Research San Diego California 92123 Recruiting
Providence Saint John s Health Center Santa Monica California 90404 Recruiting
Rocky Mountain Cancer Centers Aurora Colorado 80012 Recruiting
Vail Health Shaw Cancer Center Edwards Colorado 81632 Recruiting
Grand Valley Oncology Grand Junction Colorado 81505 Recruiting
Colorado Clinical Research Lakewood Colorado 80228 Recruiting
AdventHealth Orlando Orlando Florida 32803 Recruiting
Florida Cancer Specialists Sarasota Florida 34232 Recruiting
Winship Cancer Institute Emory University Atlanta Georgia 30322 Recruiting
Duly Health and Care Lisle Illinois 60532 Recruiting
Cancer Center of Kansas Heritage Plaza Medical Building Wichita Kansas 67214 Recruiting
St Elizabeth Healthcare Edgewood Kentucky 41017 Recruiting
Norton Cancer Institute Louisville Kentucky 40207 Recruiting
East Jefferson General Hospital Metairie Louisiana 70006 Recruiting
University of Maryland Baltimore Maryland 21201 Recruiting
Johns Hopkins Hospital Baltimore Maryland 21287 Recruiting
Johns Hopkins Medical Institutions Baltimore Maryland 21287 Recruiting
Chesapeake Urology Research Associates Towson Maryland 21204 Recruiting
Profound Research LLC at Cancer and Leukemia Center Sterling Heights Michigan 48314 Recruiting
HealthPartners Frauenshuh Cancer Center CRC West Saint Louis Park Minnesota 55426 Recruiting
HealthPartners Cancer Center at Regions Hospital CRC East Saint Paul Minnesota 55101 Recruiting
University of Mississippi Medical Center Jackson Mississippi 39216 Recruiting
Washington University St Louis Missouri 63110 Recruiting
NHO Revive Research Institute, LLC Lincoln Nebraska 68506 Recruiting
Astera Cancer Care East Brunswick New Jersey 08816 Recruiting
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island Mineola New York 11501 Recruiting
NYU Langone Health Laura and Isaac Perlmutter Cancer Center New York New York 10016 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
University of Cincinnati Cincinnati Ohio 45219 Recruiting
Oregon Urology Institute Springfield Oregon 97477 Recruiting
Lehigh Valley Hospital Allentown Pennsylvania 18103 Recruiting
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 Recruiting
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
University Of Pittsburgh Medical Center UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 Recruiting
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 Recruiting
Avera Medical Group Sioux Falls South Dakota 57105 Recruiting
Tennessee Cancer Specialists Knoxville Tennessee 37909 Recruiting
Texas Oncology Austin Texas 78731 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
Houston Metro Urology Houston Texas 77027 Recruiting
Texas Oncology 1 Sugar Land Texas 77479 Recruiting
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting
Fred Hutch Cancer Center Sloan Clinic 2 Seattle Washington 98109 Recruiting
Fred Hutchinson Cancer Research Center Seattle Washington 98109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07225946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07225946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →